|
HS Code |
885542 |
| Product Name | 2,4-Di-Tert-Butoxy-5-Bromopyrimidine |
| Cas Number | 163877-85-6 |
| Molecular Formula | C14H23BrN2O2 |
| Molecular Weight | 331.25 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Melting Point | 49-55°C |
| Solubility | Soluble in organic solvents (e.g., DMSO, dichloromethane) |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Smiles | CC(C)(C)OC1=NC(=C(N=C1OC(C)(C)C)Br) |
| Inchi | InChI=1S/C14H23BrN2O2/c1-13(2,3)18-11-9-12(15)17-14(16-11)19-10-13/h9-10H2,1-3H3 |
| Synonyms | 5-Bromo-2,4-bis(tert-butoxy)pyrimidine |
As an accredited 2,4-Di-Tert-Butoxy-5-Bromopyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2,4-Di-Tert-Butoxy-5-Bromopyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Watching the world of chemical synthesis evolve over the past decade has taught me how much progress leans on single building blocks. Among those, 2,4-Di-Tert-Butoxy-5-Bromopyrimidine stands out. It’s not the flashiest compound, and yet, it quietly sits at the center of some breakthrough chemical work. As laboratories chase cleaner routes, sharper selectivity, and better yields, this molecule steps up by offering a steadfast backbone for developing new drug candidates, advanced materials, and crop science solutions.
Synthetic chemistry at its best relies on reliable reagents. The structure of 2,4-Di-Tert-Butoxy-5-Bromopyrimidine is more than a mouthful: the tert-butoxy groups at the 2 and 4 positions protect the pyrimidine core, while the bromine at the 5-position offers a practical handle for cross-coupling. That means research groups can plug this molecule into Suzuki, Stille, or Buchwald-Hartwig reactions without wrestling with the unpredictable side reactions that older or less thoughtfully protected pyrimidines bring to the bench.
I’ve spent months testing everything from basic pyrimidines to more heavily modified versions, because tuning reactivity can either be a joy or a chore. The design of 2,4-Di-Tert-Butoxy-5-Bromopyrimidine just makes sense. Instead of worrying about nucleophilic attack at the wrong position, those tert-butoxy groups create a sturdy shield. You rarely get nasty byproducts or require tedious purification steps. On top of that, brominated pyrimidines like this one handle mild to moderate coupling conditions, unlike some chlorinated or iodinated variants which either refuse to react or fall apart if you don’t get your solvent and catalyst just right.
Working with more traditional halogenated pyrimidines always meant trade-offs. Some turn out to be unstable in the air, react too quickly with random bases, or show variable purity from batch to batch. The tert-butoxy-protected model nails consistency, especially across different suppliers. That saves time, hassle, and cost, which anyone designing a scale-up can appreciate.
The chemical structure here isn’t a happy accident. Imagine the template of a basic pyrimidine ring. Drop in the bulky tert-butoxy groups at 2 and 4, and suddenly the ring’s nitrogens resist trouble from stray nucleophiles. By placing a bromine at the 5-position—an optimal choice for palladium-catalyzed cross-couplings—researchers can then append almost any aromatic, aliphatic, or heterocyclic partner. It’s that versatility that lets research teams approach the design of kinase inhibitors, antiviral compounds, or even organic electronics from directions that would have seemed convoluted in the past.
Traditionally, chemists would labor through protection and deprotection steps, worried that the ‘protecting’ groups would complicate their own removal. The tert-butoxy groups have a clean track record: standard acidic or Lewis acid workups snap them off at the right step in synthesis, without scrambling the precious arrangements made over earlier steps. This feature makes them far more forgiving and user-friendly than methoxy or benzyl groups, which sometimes resist removal or even take the whole molecule down during the process.
I recall the first time a project team tried swapping in this compound for a similar, older bromopyrimidine in a kinase inhibitor synthesis. Integrating 2,4-Di-Tert-Butoxy-5-Bromopyrimidine bumped our product purity from the mid-80s to over 95%, with chromatography taking a fraction of the time. That pattern repeated in different research groups—whether doing small molecule libraries or optimizing active pharmaceutical ingredients. The low likelihood of forming regioisomers or over-reacted byproducts helps cut analysis time—for anyone on deadlines, that’s game-changing.
Off the bench, I’ve heard stories from materials chemists who built conjugated polymers with the help of this molecule’s robust coupling behavior. The added stability helps those working outside strictly controlled pharmaceutical labs; the product handles short-term exposure to air and moisture without decomposing, so protocols don’t stall out for minor slip-ups. Simple things like that make a real difference in throughput and cost.
Every time someone picks a reagent for C-N or C-C coupling, they weigh the cost of stability, reactivity, and functional group tolerance. Where some pyrimidines, especially those protected with groups like methyl or ethyl, come up short—with side reactions, hydrolysis, or inconsistent yields—2,4-Di-Tert-Butoxy-5-Bromopyrimidine rarely lets you down. In my time troubleshooting multi-step syntheses, batch reproducibility became easier just by switching to this model, cutting material losses and the stress that comes from unexpected decomposition.
Using chlorinated or iodinated versions in the same cross-coupling steps often demands stronger conditions—higher temperatures, specialized ligands, or rare catalysts. That boost in harshness can spell trouble for downstream sensitive functionality. The bromine handles broader conditions. It works with garden-variety coupling protocols and avoids demands for the most expensive or finicky catalysts.
I’ve seen synthetic teams avoid this compound out of habit, only to circle back after less-protected or less-selective reagents swap convenience for tough workups or nagging purity issues. The tert-butoxy groups, being sterically bulky without being too electron-donating or -withdrawing, hit a sweet spot. They stabilize the ring, guard against mischief during reactions, and leave gracefully when you’re ready for the final transformation.
Product quality, a theme hammered home in our group, often perches on subtle differences. 2,4-Di-Tert-Butoxy-5-Bromopyrimidine tends to come as a fine, off-white crystalline powder, typically with purity levels north of 98%. Small impurities sometimes lurk, but most reputable suppliers keep residual solvents and side products at negligible levels. Compared to sticky oils or air-sensitive solids, this one ships and stores in regular containers without drama. That ease of handling can speed up both lab and manufacturing work, with fewer special requirements for atmospheric control.
I once watched a project slow to a crawl on account of low-yielding couplings with a methyl-protected pyrimidine. Switching to the tert-butoxy version not only improved reaction rates but cut down on the slurries and solubility problems that plagued product isolation. Those tert-butoxy groups, being bulky yet ready to depart, help both the solubility and crystallinity of intermediates and products.
Synthetic chemists working in drug discovery always look for reliable building blocks to streamline the hunt for new activity. 2,4-Di-Tert-Butoxy-5-Bromopyrimidine lets teams bypass some of the classic bottlenecks. In early lead development, where combinatorial chemistry can run dozens or hundreds of reactions in parallel, having a robust and forgiving bromopyrimidine means fewer costly failed syntheses, more lead compounds to test, and less labor just making intermediates.
The molecule also opens doors in heterocyclic scaffolding, letting teams swap in new aryl groups, amino substituents, or heterocyclic partners at the 5-position. This flexibility makes it a solid foundation in the synthesis of kinase, phosphodiesterase, and other enzyme inhibitor cores. One research project I remember reworked an entire SAR (structure-activity relationship) series using this compound, gaining better metabolic stability in the analogues and hitting the right water solubility balance.
In crop science, creating new agrochemical actives often means swapping out one part of a heterocycle for another, searching for the perfect balance of potency and safety. The tert-butoxy-protected bromopyrimidine allows easy access to diversified analogues without bottlenecks that plague traditional scaffolds.
Across materials science, using this building block unlocks modifications for organic light-emitting diodes, coordination polymers, and charge-transport materials. It offers a rare combination of stability, functionalizability, and leaving group properties that speed up lab-scale exploration and eventually scale-up for pilot production.
No one in research or production wants to baby their reagents more than necessary. 2,4-Di-Tert-Butoxy-5-Bromopyrimidine doesn’t ask for dryboxes or argon-filled glove bags. As long as it stays capped, it weathers short lab bench exposures, so researchers don’t have to panic over a few minutes in the open air. The powder handles common shipping and storage. I’ve seen containers hold up just fine a year after purchase, with no sign of caking or browning, so the shelf life (under reasonable lab conditions) tracks well with other robust heterocycles.
For those running kilo-scale or pilot plant campaigns, the chemical’s physical properties—such as reasonable melting point and manageable solubility—cut down on headaches during isolation and transfer steps. It doesn’t foul glassware or emit noxious vapors, so even junior chemists get up to speed quickly in handling and weighing. Compared to some air- or moisture-sensitive intermediates, the stability here helps lower training barriers and safety risks.
Regulatory focus on reagent choice is only getting stronger. Hazard profiles always matter. 2,4-Di-Tert-Butoxy-5-Bromopyrimidine ranks in the middle ground: not as gentle as table sugar, but much friendlier to work with than compounds bearing strong oxidizers, azides, or unstable halides. Generally non-volatile and with mild reactivity, it doesn’t pose unusual inhalation hazards. As long as basic gloves and splash-proof goggles are in use, the day-to-day safety is straightforward. Like most organobromides, waste management needs sensible steps—collecting and segregating halogenated solvents and byproducts to meet disposal standards.
For teams mindful of green chemistry, this compound can cut down on total solvent and purification needs. Reactions that run clean keep downstream waste to a minimum, lightening both the environmental impact and time spent on costly purification. If reactivity adjusts to mild, shorter steps, labs can also slash total process time, energy use, and water consumption.
Every molecule comes with its quirks. 2,4-Di-Tert-Butoxy-5-Bromopyrimidine has its critics, mostly around cost and supply chain. The tert-butoxy groups make the synthesis more involved than simple alkyl or halogenated variants, which can bump up price, especially during shortages or when starting material prices spike. I’ve heard headaches from teams forced to switch to less robust analogues during supply crunches, only to circle back with more appreciation after quality or yield drops.
That said, the demand for reliable, high-purity pyrimidines isn’t going anywhere. I’ve seen collaborations accelerate when teams had a supply of this compound, since it lets medicinal chemistry overlap with process chemistry, cutting the cycle times between hit identification and scale-up optimization. There’s still room for broader production automation, as well as greener solvent and reagent management, to drive costs and ecological impact down.
It’s also worth remembering that no building block solves every problem by itself. The tert-butoxy groups, while a blessing for many steps, may not always survive harsh oxidative conditions or extended high-temperature treatments. Careful route planning remains key. Access to expanded derivatives—with other leaving groups or protection patterns—can supplement this product’s reach, letting teams pivot quickly if a specific synthetic step turns difficult.
Reflecting on how far small-molecule synthesis has come, it’s clear how much even modest improvements ripple through research programs. In my own work—whether building kinase inhibitors, prepping intermediates for materials projects, or troubleshooting stubborn coupling reactions—I’ve seen how switching to 2,4-Di-Tert-Butoxy-5-Bromopyrimidine brings a kind of stability that bigger, more expensive technological leaps often promise but rarely deliver at the bench. The straightforward chemistry, clean reactivity, and stress-free handling reflect a philosophy that smart molecular engineering removes hurdles for both discovery scientists and process teams. Researchers can spend more time innovating, less time solving problems the right building block already anticipated.
That sort of reliability, measured not only in lab time saved but headaches avoided, ranks as a quietly radical contribution to chemical progress. Every once in a while, a particular reagent comes along that lets you shelve your bench frustrations and rediscover the part of the job that's meant to be creative. In my experience, 2,4-Di-Tert-Butoxy-5-Bromopyrimidine is one of those rare finds.